Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice

European Neuropsychopharmacology

Volumn 21, Issue 5, 2011, Pages 401-413

  Singer, Philipp ^a   Boison, Detlev ^b   Möhler, Hanns ^a,c,d   Feldon, Joram ^a   Yee, Benjamin K ^a  

^a ETH ZURICH   (Switzerland)

^b LEGACY RESEARCH   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Swiss Federal Institute of Technology Collegium Helveticum   (Switzerland)

Author keywords

Attention; Glutamate; Glycine; NMDA; Schizophrenia

Indexed keywords

DIZOCILPINE; GLYCINE TRANSPORTER 1;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CELL SPECIFICITY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FOREBRAIN; GENE DELETION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY GATING; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; FEMALE; GENE DELETION; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HABITUATION, PSYCHOPHYSIOLOGIC; INHIBITION (PSYCHOLOGY); MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; PROSENCEPHALON; SENSORY GATING; STARTLE REACTION;

EID: 79953756501     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.06.014     Document Type: Article

References (88)

1. Adams R.H., Sato K., Shimada S., Tohyama M., Püschel A.W., Betz H. Gene structure and glial expression of the glycine transporter GlyT1 in embryonic and adult rodents. J. Neurosci. 1995, 15:2524-2532.
2. Aragón C., López-Corcuera B. Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion. Trends Pharmacol. Sci. 2005, 26:283-286.
3. Bast T., Zhang W.N., Heidbreder C., Feldon J. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience 2001, 103:325-335.
4. Behrens M.M., Ali S.S., Dao D.N., Lucero J., Shekhtman G., Quick K.L., Dugan L.L. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 2007, 318:1645-1647.
5. Berger A.J., Dieudonne S., Ascher P. Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J. Neurophysiol. 1998, 80:3336-3340.
6. Bergeron R., Meyer T.M., Coyle J.T., Greene R.W. Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15730-15734.
7. Betz H., Gomeza J., Armsen W., Scholze P., Eulenburg V. Glycine transporters: essential regulators of synaptic transmission. Biochem. Soc. Trans. 2006, 34:55-58.
8. Bolino F., Di Michele V., Di Cicco L., Manna V., Daneluzzo E., Casacchia M. Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia. Biol. Psychiatry 1994, 36:669-670.
9. Borowsky B., Hoffman B.J. Analysis of a gene encoding two glycine transporter variants reveals alternative promoter usage and a novel gene structure. J. Biol. Chem. 1998, 273:29077-29085.
10. Boulay D., Pichat P., Dargazanli G., Estenne-Bouhtou G., Terranova J.P., Rogacki N., Stemmelin J., Coste A., Lanneau C., Desvignes C., Cohen C., Alonso R., Vigé X., Biton B., Steinberg R., Sevrin M., Oury-Donat F., George P., Bergis O., Griebel G., Avenet P., Scatton B. Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacol. Biochem. Behav. 2008, 91:47-58.
11. Braff D.L., Stone C., Callaway E., Geyer M.A., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
12. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry 1992, 49:206-215.
13. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156:234-258.
14. Breier A., Malhotra A.K., Pinals D.A., Weisenfeld N.I., Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry 1997, 154:805-811.
15. Briata P., Di Blas E., Gulisano M., Mallamaci A., Iannone R., Boncinelli E., Corte G. EMX1 homeoprotein is expressed in cell nuclei of the developing cerebral cortex and in the axons of the olfactory sensory neurons. Mech. Dev. 1996, 57:169-180.
16. Buckland G., Buckland J., Jamieson C., Ison J.R. Inhibition of startle response to acoustic stimulation produced by visual prestimulation. J. Comp. Physiol. Psychol. 1969, 67:493-496.
17. Cabib S., Puglisi-Allegra S., Ventura R. The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav. Brain. Res. 2002, 130:103-109.
18. Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006, 39:10-14.
19. Chen L., Muhlhauser M., Yang C.R. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. J. Neurophysiol. 2003, 89:691-703.
20. Clements J.D., Westbrook G.L. Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor. Neuron 1991, 7:605-613.
21. Csomor P.A., Yee B.K., Vollenweider F.X., Feldon J., Nicolet T., Quednow B.B. On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav. Neurosci. 2008, 122:885-900.
22. Curras M.C., Pallotta B.S. Single-channel evidence for glycine and NMDA requirement in NMDA receptor activation. Brain. Res. 1996, 740:27-40.
23. Depoortère R., Dargazanli G., Estenne-Bouhtou G., Coste A., Lanneau C., Desvignes C., Poncelet M., Heaulme M., Santucci V., Decobert M., Cudennec A., Voltz C., Boulay D., Terranova J.P., Stemmelin J., Roger P., Marabout B., Sevrin M., Vigé X., Biton B., Steinberg R., Françon D., Alonso R., Avenet P., Oury-Donat F., Perrault G., Griebel G., George P., Soubrié P., Scatton B. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology 2005, 30:1963-1985.
24. Deutsch S.I., Rosse R.B., Schwartz B.L., Mastropaolo J. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin. Neuropharmacol. 2001, 24:43-49.
25. Dingledine R., Kleckner N.W., McBain C.J. The glycine coagonist site of the NMDA receptor. Adv. Exp. Med. Biol. 1990, 268:17-26.
26. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull. 2009, 35:528-548.
27. Fejgin K., Pålsson E., Wass C., Finnerty N., Lowry J., Klamer D. Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide. Neuropsychopharmacology 2009, 34:1673-1684.
28. Fendt M., Li L., Yeomans J.S. Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology 2001, 156:216-224.
29. Gabernet L., Pauly-Evers M., Schwerdel C., Lentz M., Bluethmann H., Vogt K., Alberati D., Mohler H., Boison D. Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci. Lett. 2005, 373:79-84.
30. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001, 156:117-154.
31. Geyer M.A., McIlwain K.L., Paylor R. Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry 2002, 7:1039-1053.
32. Graham F.K. The more or less startling effects of weak prestimulation. Psychophysiology 1975, 12:238-248.
33. Grillon C., Ameli R., Charney D.S., Krystal J.H., Braff D.L. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry 1992, 32:843-939.
34. Gulisano M., Broccoli V., Pardini C., Boncinelli E. Emx1 and Emx2 show different patterns of expression during proliferation and differentiation of the developing cerebral cortex in the mouse. Eur. J. Neurosci. 1996, 8:1037-1050.
35. Hauser J., Rudolph U., Keist R., Möhler H., Feldon J., Yee B.K. Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition. Mol. Psychiatry 2005, 10:201-207.
36. Heresco-Levy U., Bar G., Levin R., Ermilov M., Ebstein R.P., Javitt D.C. High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr. Res. 2007, 91:14-21.
37. Hoffman H.S., Searle J.L. Acoustic variables in the modification of startle reaction in the rat. J. Comp. Physiol. Psychol. 1965, 60:53-58.
38. Iwasato T., Datwani A., Wolf A.M., Nishiyama H., Taguchi Y., Tonegawa S., Knopfel T., Erzurumlu R.S., Itohara S. Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex. Nature 2000, 406:726-731.
39. Javitt D.C. Glycine transport inhibitors and the treatment of schizophrenia. Biol. Psychiatry 2008, 63:6-8.
40. Javitt D.C. Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. Curr. Opin. Drug. Discov. Dev. 2009, 12:468-478.
41. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987, 325:529-531.
42. Keck T., White J.A. Glycinergic inhibition in the hippocampus. Rev. Neurosci. 2009, 20:13-22.
43. Kinney G.G., Sur C., Burno M., Mallorga P.J., Williams J.B., Figueroa D.J., Wittmann M., Lemaire W., Conn P.J. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J. Neurosci. 2003, 23:7586-7591.
44. Koch M., Schnitzler H.U. The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation. Behav. Brain Res. 1997, 89:35-49.
45. Kodsi M.H., Swerdlow N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav. Neurosci. 1995, 109:912-928.
46. Kretschmer B.D., Koch M. Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating: a behavioral and microdialysis study. Psychopharmacology 1997, 130:131-138.
47. Le Pen G., Kew J., Alberati D., Borroni E., Heitz M.P., Moreau J.L. Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor. Biol. Psychiatry 2003, 54:1162-1170.
48. Lerma J., Zukin R.S., Bennett M.V. Glycine decreases desensitization of N-methyl-D-aspartate (NMDA) receptors expressed in Xenopus oocytes and is required for NMDA responses. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2354-2358.
49. Lin Q., Peng Y., Willis W.D. Glycine and GABAA antagonists reduce the inhibition of primate spinothalamic tract neurons produced by stimulation in periaqueductal gray. Brain Res. 1994, 654:286-302.
50. Lipina T., Labrie V., Weiner I., Roder J. Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology 2005, 179:54-67.
51. López-Corcuera B., Geerlings A., Aragón C. Glycine neurotransmitter transporters: an update. Mol. Membr. Biol. 2001, 18:13-20.
52. Lynch J.W. Molecular structure and function of the glycine receptor chloride channel. Physiol. Rev. 2004, 84:1051-1095.
53. Martina M., Gorfinkel Y., Halman S., Lowe J.A., Periyalwar P., Schmidt C.J., Bergeron R. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J. Physiol. 2004, 557:489-500.
54. Mayer M.L., Vyklicky L., Clements J. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 1989, 338:425-427.
55. McCaughran J., Mahjubi E., Decena E., Hitzemann R. Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition. Psychopharmacology (Berl.) 1997, 134:131-139.
56. Möhler H., Rudolph U., Boison D., Singer P., Feldon J., Yee B.K. Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1. Pharmacol. Biochem. Behav. 2008, 90:58-64.
57. Nong Y., Huang Y.Q., Ju W., Kalia L.V., Ahmadian G., Wang Y.T., Salter M.W. Glycine binding primes NMDA receptor internalization. Nature 2003, 422:302-307.
58. Olivier B., Leahy C., Mullen T., Paylor R., Groppi V.E., Sarnyai Z., Brunner D. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics. Psychopharmacology 2001, 156:284-290.
59. Ouagazzal A.M., Jenck F., Moreau J.L. Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?. Psychopharmacology (Berl.) 2001, 156:273-283.
60. Parwani A., Duncan E., Bartlett E., Madonick S., Efferen T.R., Rajan R., Sanfilipo M., Chappell P.B., Chakravorty S., Gonzenbach S., Ko G.N., Rotrosen J.P. Impaired prepulse inhibition of acoustic startle in schizophrenics. Biol. Psychiatry 2000, 47:662-669.
61. Patel N., Hitzemann B., Hitzemann R. Genetics, haloperidol, and the Fos response in the basal ganglia: a comparison of the C57BL/6J and DBA/2J inbred mouse strains. Neuropsychopharmacology 1998, 18:480-491.
62. Perry K.W., Falcone J.F., Fell M.J., Ryder J.W., Yu H., Love P.L., Katner J., Gordon K.D., Wade M.R., Man T., Nomikos G.G., Phebus L.A., Cauvin A.J., Johnson K.W., Jones C.K., Hoffmann B.J., Sandusky G.E., Walter M.W., Porter W.J., Yang L., Merchant K.M., Shannon H.E., Svensson K.A. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas. Neuropharmacology 2008, 55:743-754.
63. Puglisi-Allegra S., Cabib S. Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice. Prog. Neurobiol. 1997, 51:637-661.
64. Puglisi-Allegra S., Kempf E., Cabib S. Role of genotype in the adaptation of the brain dopamine system to stress. Neurosci. Biobehav. Rev. 1990, 14:523-528.
65. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 2005, 10:434-449.
66. Reijmers L.G., Vanderheyden P.M., Peeters B.W. Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens. Eur. J. Pharmacol. 1995, 272:131-138.
67. Schweizer C., Balsiger S., Bluethmann H., Mansuy I.M., Fritschym J.-M., Mohler H., Luscher B. The α2 subunit of GABAA receptors is required for maintenance of receptors at mature synapses. Mol. Cell. Neurosci. 2003, 24:442-450.
68. Singer P., Boison D., Möhler H., Feldon J., Yee B.K. Enhanced recognition memory following glycine transporter 1 deletion in forebrain neurons. Behav. Neurosci. 2007, 121:815-825.
69. Singer P., Feldon J., Yee B.K. Interference of glycine transporter 1: modulation of cognitive functions via activation of glycine-B site of the NMDA receptor. CNS Agents Med. Chem. 2007, 7:259-268.
70. Singer P., Boison D., Möhler H., Feldon J., Yee B.K. Deletion of glycine transporter 1 (GlyT1) in forebrain neurons facilitates reversal learning: enhanced cognitive adaptability?. Behav. Neurosci. 2009, 123:1012-1027.
71. Singer P., Feldon J., Yee B.K. Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice. Psychopharmacology 2009, 206:677-698.
72. Singer P., Yee B.K., Feldon J., Iwasato T., Itohara S., Grampp T., Prenosil G., Benke D., Möhler H., Boison D. Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1. Neuroscience 2009, 161:635-654.
73. Smith K.E., Borden L.A., Hartig P.R., Branchek T., Weinshank R.L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 1992, 8:927-935.
74. Swerdlow N.R., Geyer M.A. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol. Biochem. Behav. 1993, 44:741-744.
75. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl.) 2008, 199:331-388.
76. Tsai G., Ralph-Williams R.J., Martina M., Bergeron R., Berger-Sweeney J., Dunham K.S., Jiang Z., Caine S.B., Coyle J.T. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8485-8490.
77. Tsien J.Z., Chen D.F., Gerber D., Tom C., Mercer E.H., Anderson D.J., Mayford M., Kandel E.R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 1996, 87:1317-1326.
78. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 2007, 33:69-94.
79. Waziri R., Baruah S. A hyperglycinergic rat model for the pathogenesis of schizophrenia: preliminary findings. Schizophr. Res. 1999, 37:205-215.
80. Webb T.I., Lynch J.W. Molecular pharmacology of the glycine receptor chloride channel. Curr. Pharm. Des. 2007, 13:2350-2367.
81. Yang S.Y., Hong C.J., Huang Y.H., Tsai S.J. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats. Neurosci. Lett. 2010, 469:127-130.
82. Yee B.K., Chang D.L., Feldon J. The effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice. Neuropsychopharmacology 2004, 29:1865-1877.
83. Yee B.K., Tilly C., Pietropaolo S., Feldon J. The expression of prepulse inhibition of the acoustic startle reflex as a function of three pulse stimulus intensities, three prepulse stimulus intensities, and three levels of startle responsiveness in C57BL6/J mice. Behav. Brain Res. 2005, 163:265-276.
84. Yee B.K., Balic E., Singer P., Schwerdel C., Grampp T., Gabernet L., Knuesel I., Benke D., Feldon J., Mohler H., Boison D. Disruption of glycine, transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J. Neurosci. 2006, 26:3169-3181.
85. Yoshida M., Suda Y., Matsuo I., Miyamoto N., Takeda N., Kuratani S., Aizawa S. Emx1 and Emx2 functions in development of dorsal telencephalon. Development 1997, 124:101-111.
86. Zhang W., Pouzet B., Jongen-Rêlo A.L., Weiner I., Feldon J. Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. Neuroreport 1999, 10:2533-2538.
87. Zhang W.N., Bast T., Feldon J. Effects of hippocampal N-methyl-D-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. Behav. Neurosci. 2002, 116:72-84.
88. Zhang L.H., Gong N., Fei D., Xu L., Xu T.L. Glycine uptake regulates hippocampal network activity via glycine receptor-mediated tonic inhibition. Neuropsychopharmacology 2008, 33:701-711.